Product Program year 2024 Source: CMS Open Payments

NP Thyroid 60

Drug Hyperthyroidism

NDC 42192-330-01

Open in the dashboard

General payments

$277,355

4,052 payments

Research payments

$0

0 payments

Through program year 2024, $277,355 in general payments and $0 in research payments were reported against NP Thyroid 60 (Hyperthyroidism).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $105,370 2,014
2023 General $129,045 1,625
2022 General $18,543 269
2021 General $24,397 144

Breakdown

Who paid General payments · program years 2021–2024
  1. Acella Pharmaceuticals, LLC $271,943 3,772 payments
  2. Avion Pharmaceuticals $5,412 280 payments
Top recipients General payments · program year 2024
  1. Elizabeth McAninch Endocrinology, Diabetes & Metabolism · Stanford, CA $15,193 14% · 6 payments
  2. Thanh Hoang Endocrinology, Diabetes & Metabolism · Bethesda, MD $11,807 11% · 5 payments
  3. David Robertson Endocrinology, Diabetes & Metabolism · Atlanta, GA $11,231 11% · 2 payments
  4. Mandy Cotten Nurse Practitioner, Family · Arlington, TX $8,996 9% · 4 payments
  5. Angela Mazza Endocrinology, Diabetes & Metabolism · Orlando, FL $8,942 8% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $52,893 51% · 241 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $24,965 24% · 356 practitioners
  3. Family Medicine $6,379 6% · 295 practitioners
  4. Nurse Practitioner, Women's Health Nurse Practitioner $5,430 5% · 19 practitioners
  5. Internal Medicine $3,441 3% · 162 practitioners

The top 5 of 70 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $23,920 23% · 176 recipients
  2. Texas $16,652 16% · 310 recipients
  3. Florida $14,955 14% · 177 recipients
  4. Maryland $12,534 12% · 33 recipients
  5. Georgia $12,287 12% · 58 recipients

The top 5 of 40 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

66,015

Prescriptions dispensed, refills included

Drug cost

$3,632,825

Paid at the pharmacy, in all

Prescribers

3,041

With 11 or more claims of it

Medicare Part D drugs matched to NP Thyroid 60, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Np Thyroid Thyroid,pork Similar name 3,041 66,015 $3,632,825

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Robert Hogue Family Practice TX 455 $20,958 None on record
Gary Sharpless Internal Medicine TX 232 $18,197 None on record
Alan Rauba Endocrinology MO 227 $19,796 $18
Billy May General Practice LA 224 $8,955 None on record
Mark Hertzberg Internal Medicine MI 223 $11,466 $24

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron
4,052 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record